Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
A concise primer on initial crypto choices, risk awareness, and how to approach your first investment with clarity.
19,456 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Rivian has captured investor attention again as the stock trades under $20. This guide breaks down whether a $5,000 i...
As AI leaders consolidate influence, Anthropic's Dario Amodei warns of rapid, perhaps accidental power concentrated i...
Peek behind the curtain of a renowned star’s private life. This fictional profile of the Neill family reveals how mon...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Renewed Iran tensions push Treasury yields higher and lift mortgage costs, threatening affordability for buyers and h...
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
When memory stocks spark market optimism, chipmakers can drive broader gains. This piece breaks down what’s behind th...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
SoFi Technologies could be on the verge of a significant rerating as revenue and members keep growing. This guide div...
Trade Desk beat Q4 expectations but issued softer Q1 guidance, sparking a swift market reaction as investors weigh sl...
Root Insurance posted its first underwriting profit in 2025, delivering $40.3 million in net income on $1.5 billion i...